Literature DB >> 22665405

Preeclampsia and retinopathy of prematurity in preterm births.

Xiao Dan Yu1, D Ware Branch, S Ananth Karumanchi, Jun Zhang.   

Abstract

OBJECTIVE: The relationship between gestational hypertension, preeclampsia, and the risk of retinopathy of prematurity (ROP) remains unclear. Thus, we used a large cohort database to study the influence of maternal gestational hypertension and preeclampsia on the occurrence of ROP in preterm infants.
METHODS: We used data from a previous retrospective cohort study that includes 25,473 eligible preterm neonates. We examined the association between gestational hypertension, preeclampsia, and ROP while controlling for potential confounders by multiple logistic regression analysis.
RESULTS: Of the 8758 early preterm infants (gestational age <34 weeks), 1024 (11.69%) had ROP, while of the 16,715 late preterm infants, only 29 (0.17%) had ROP. After adjusting for confounders, preeclampsia was associated with a significantly reduced risk of ROP (adjusted odds ratio [aOR], 0.65; 95% confidence interval [CI], 0.49-0.86 for early preterm birth; aOR, 0.10; 95% CI, 0.01-0.93 for late preterm birth; aOR, 0.66; 95% CI, 0.50-0.87 for all preterm births). Gestational hypertension was not significantly associated with ROP at early or late preterm births.
CONCLUSIONS: Preeclampsia, but not gestational hypertension, was associated with a reduced risk of ROP in preterm births.

Entities:  

Mesh:

Year:  2012        PMID: 22665405      PMCID: PMC8194485          DOI: 10.1542/peds.2011-3881

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  39 in total

1.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

2.  [Prevalence and risk factors of retinopathy of prematurity].

Authors:  Dong-Mei Huo; Fang-Tian Dong; Rong-Ping Dai; Jie Chu; Wei-Hong Yu
Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao       Date:  2006-08

3.  Preeclampsia and soluble fms-like tyrosine kinase 1.

Authors:  James M Roberts; Augustine Rajakumar
Journal:  J Clin Endocrinol Metab       Date:  2009-07       Impact factor: 5.958

4.  Retinopathy of prematurity in small-for-gestational age infants compared with those of appropriate size for gestational age.

Authors:  C A Dhaliwal; B W Fleck; E Wright; C Graham; N McIntosh
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2008-09-11       Impact factor: 5.747

Review 5.  Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy.

Authors:  James M Roberts; Gail Pearson; Jeff Cutler; Marshall Lindheimer
Journal:  Hypertension       Date:  2003-02-10       Impact factor: 10.190

6.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

Authors:  Richard J Levine; Chun Lam; Cong Qian; Kai F Yu; Sharon E Maynard; Benjamin P Sachs; Baha M Sibai; Franklin H Epstein; Roberto Romero; Ravi Thadhani; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2006-09-07       Impact factor: 91.245

7.  Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

Authors:  Helen A Mintz-Hittner; Kathleen A Kennedy; Alice Z Chuang
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

8.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Authors:  L P Aiello; E A Pierce; E D Foley; H Takagi; H Chen; L Riddle; N Ferrara; G L King; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction.

Authors:  Chao-Nin Wang; Shuenn-Dyh Chang; Hsiu-Huei Peng; Yun-Shien Lee; Yao-Lung Chang; Po-Jen Cheng; An-Shine Chao; Tzu-Hao Wang; Hsin-Shih Wang
Journal:  J Clin Endocrinol Metab       Date:  2010-01-15       Impact factor: 5.958

10.  A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity.

Authors:  J T Flynn; E Bancalari; E S Snyder; R N Goldberg; W Feuer; J Cassady; J Schiffman; H I Feldman; B Bachynski; E Buckley
Journal:  N Engl J Med       Date:  1992-04-16       Impact factor: 91.245

View more
  22 in total

Review 1.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

2.  Incidence and risk factors for retinopathy of prematurity in extreme low birth weight Chinese infants.

Authors:  Gordon S K Yau; Jacky W Y Lee; Victor T Y Tam; Catherine C L Liu; Benjamin C Y Chu; Can Y F Yuen
Journal:  Int Ophthalmol       Date:  2014-06-05       Impact factor: 2.031

3.  Causal inference in studies of preterm babies: a simulation study.

Authors:  J M Snowden; O Basso
Journal:  BJOG       Date:  2017-10-30       Impact factor: 6.531

4.  Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth.

Authors:  Pauline Mendola; Sunni L Mumford; Tuija I Männistö; Alexander Holston; Uma M Reddy; S Katherine Laughon
Journal:  Epidemiology       Date:  2015-01       Impact factor: 4.822

Review 5.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

6.  The curse of the perinatal epidemiologist: inferring causation amidst selection.

Authors:  Jonathan M Snowden; Marit L Bovbjerg; Mekhala Dissanayake; Olga Basso
Journal:  Curr Epidemiol Rep       Date:  2018-09-27

Review 7.  Pre-eclampsia: pathogenesis, novel diagnostics and therapies.

Authors:  Elizabeth A Phipps; Ravi Thadhani; Thomas Benzing; S Ananth Karumanchi
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

8.  Pre-eclampsia and the risk of retinopathy of prematurity in preterm infants with birth weight <1500 g and/or <31 weeks' gestation.

Authors:  Belal Alshaikh; Omar Salman; Nancy Soliman; Anna Ells; Kamran Yusuf
Journal:  BMJ Open Ophthalmol       Date:  2017-06-19

9.  Association of Maternal Preeclampsia With Infant Risk of Premature Birth and Retinopathy of Prematurity.

Authors:  Julia P Shulman; Cindy Weng; Jacob Wilkes; Tom Greene; M Elizabeth Hartnett
Journal:  JAMA Ophthalmol       Date:  2017-09-01       Impact factor: 7.389

10.  Hypertensive disorders of pregnancy and outcomes of preterm infants of 24 to 28 weeks' gestation.

Authors:  L Gemmell; L Martin; K E Murphy; N Modi; S Håkansson; B Reichman; K Lui; S Kusuda; G Sjörs; L Mirea; B A Darlow; R Mori; S K Lee; P S Shah
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.